ChromaDex Q3 2023 Gaap EPS $(0.01) Beats $(0.03) Estimate, Sales $19.50M Miss $20.25M Estimate
Portfolio Pulse from saritha@benzinga.com
ChromaDex reported Q3 2023 GAAP EPS of $(0.01), beating the estimate of $(0.03) by 66.67%. However, the company's sales of $19.50M missed the estimate of $20.25M by 3.73%. This represents a 75% increase in EPS and a 14.25% increase in sales compared to the same period last year.
November 08, 2023 | 9:46 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
ChromaDex's Q3 2023 results beat EPS estimates but missed on sales. This could have mixed implications for the stock.
ChromaDex's EPS beat estimates, which is a positive signal for investors and could drive the stock price up. However, the company missed on sales, which could negatively impact the stock as it indicates lower-than-expected revenue. The net effect on the stock price could be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100